Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 16/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 11/20 | 0.63 |
| ▸ | SLC6A3 | Q01959 | 7/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1257763 | 0.82 | SLC6A4 (0.55) | SLC6A4SLC6A2SLC6A3TDP1 | |
| SCHEMBL125255 | 0.82 | ALDH1A1 (0.57) | SLC6A4SLC6A2SLC6A3ALDH1A1TSHR | |
| SCHEMBL29729780 | 0.82 | ALDH1A1 (0.57) | SLC6A4SLC6A2SLC6A3ALDH1A1TSHR | |
| SCHEMBL5913443 | 0.80 | SLC6A4 (0.53) | SLC6A4SLC6A2SLC6A3TDP1ALDH1A1 | |
| SCHEMBL32667982 | 0.80 | ALOX15 (0.45) | SLC6A4SLC6A2SLC6A3TDP1ALDH1A1 | |
| Questiomycin B SCHEMBL16239659 | 0.80 | SLC6A4 (0.57) | SLC6A4SLC6A2SLC6A3TDP1ALDH1A1 | |
| SCHEMBL20467041 | 0.79 | SLC6A4 (0.43) | SLC6A4SLC6A2SLC6A3TDP1 | |
| SCHEMBL248661 | 0.79 | SLC6A4 (0.51) | SLC6A4SLC6A2SLC6A3TDP1 | |
| SCHEMBL28498759 | 0.79 | HDAC3 (0.46) | SLC6A4SLC6A2SLC6A3ALDH1A1 | |
| SCHEMBL8533846 | 0.78 | SLC6A4 (1.00) | SLC6A4SLC6A2SLC6A3TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120184645-A1 | RESINOUS DISPERSIONS INCLUDING AN EPOXY AMINE ADDUCT FOR FLATTING AND RELATED ELECTRODEPOSITABLE COATING COMPOSITIONS | PPG INDUSTRIES OHIO, INC. (US) | 2012-07-19 | — | — | US | claimed |
| US-12310944-B2 | Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof | CHINA PHARMACEUTICAL UNIVERSITY (CN) | 2025-05-27 | — | — | US | disclosed |
| US-20230165833-A1 | Selective Butyrylcholinesterase Inhibitor or Pharmaceutically Acceptable Salt Thereof, Preparation Method and Use Thereof | CHINA PHARMACEUTICAL UNIVERSITY (CN) | 2023-06-01 | — | — | US | disclosed |
| US-20210380592-A1 | COMPOUND HAVING BENZO SEVEN-MEMBERED RING STRUCTURE, PREPARATION METHOD THEREFOR, AND USE THEREOF | BIONNA (BEIJING) MEDICAL TECHNOLOGY CO., LTD. (CN) | 2021-12-09 | — | — | US | disclosed |
| EP-3919479-A1 | COMPOUND HAVING BENZO SEVEN-MEMBERED RING STRUCTURE, PREPARATION METHOD THEREFOR, AND USE THEREOF | Bionna (Beijing) Medical Technology Co., Ltd. (CN) | 2021-12-08 | — | — | EP | disclosed |
| WO-2021042410-A1 | SELECTIVE BUTYRYLCHOLINESTERASE INHIBITOR OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 中国药科大学 | 2021-03-11 | — | — | WO | disclosed |
| EP-3696174-A1 | HETEROCYCLIC MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | Vertex Pharmaceuticals Incorporated (US) | 2020-08-19 | — | — | EP | disclosed |
| WO-2020156357-A1 | COMPOUND HAVING BENZO SEVEN-MEMBERED RING STRUCTURE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 博诺康源(北京)药业科技有限公司 | 2020-08-06 | — | — | WO | disclosed |
| EP-3152202-B1 | 3,5-DICHLORO,4-(3,4-(CYCLO-)ALKOXYPHENYL)--2-CARBONYLOXY)ETHYL)PYRIDINE DERIVATIVES AS PDE-4 INHIBITORS AND MUSCARINIC M3 RECEPTOR ANTAGONISTS | CHIESI FARM SPA (IT) | 2018-11-28 | — | — | EP | disclosed |
| US-10087176-B2 | 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitors | CHIESI FARMACEUTICI S.P.A. (IT) | 2018-10-02 | — | — | US | disclosed |
| US-5852030-A | Indole derivatives, process for producing the same and medicinal uses of the same | TORAY INDUSTRIES, INC. (JP) | 1998-12-22 | — | — | US | disclosed |
| WO-1998038378-A1 | CARBAMATE MODIFIED LOW-MOLECULAR POLYMER COMPOUND AND THE USE THEREOF FOR AFTER-TREATMENT OF DYED OR PRINTED CELLULOSE TEXTILE MATERIAL | TEXTILCOLOR AG (CH) | 1998-09-03 | — | — | WO | disclosed |
| EP-0492501-B1 | Surface-active triazine compounds, process for their preparation and their use | HOECHST AG (DE) | 1996-11-20 | — | — | EP | disclosed |
| EP-0614898-A1 | INDOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL USE THEREOF | TORAY INDUSTRIES, INC. (JP) | 1994-09-14 | — | — | EP | disclosed |
| US-5240499-A | Polymeric pigments | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-08-31 | — | — | US | disclosed |
| EP-0492501-A1 | Surface-active triazine compounds, process for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-07-01 | — | — | EP | disclosed |
| US-4676803-A | Reactive azo dyestuffs, free from anionic groups and containing a basic group and halogenotriazinyl radical and useful for dyeing cellulose/polyester | BAYER AKTIENGESELLSCHAFT (DE) | 1987-06-30 | — | — | US | disclosed |
| EP-0022209-B1 | FLUOR-TRIAZINE DYESTUFFS AND THEIR USE IN DYEING CELLULOSIC FIBROUS MATERIALS | BAYER AG (DE) | 1985-04-17 | — | — | EP | disclosed |
| US-4503224-A | FIBER-REACTIVE, COTTON-POLYESTER BLENDS | BAYER AKTIENGESELLSCHAFT (DE) | 1985-03-05 | — | — | US | disclosed |
| EP-0022209-A2 | Fluor-triazine dyestuffs and their use in dyeing cellulosic fibrous materials | BAYER AG (DE) | 1981-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165833-A1 | Selective Butyrylcholinesterase Inhibitor or Pharmaceutically Acceptable Salt Thereof, Preparation Method and Use Thereof | BCHE, ACHE, BACE1 | SLC6A4 86/4885SLC6A2 9/4885SLC6A3 60/4885 |
| US-20210380592-A1 | COMPOUND HAVING BENZO SEVEN-MEMBERED RING STRUCTURE, PREPARATION METHOD THEREFOR, AND USE THEREOF | BRD4, BRD7, BICRA | SLC6A4 3089/4885SLC6A2 4173/4885SLC6A3 3586/4885 |
| US-10087176-B2 | 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitors | PDE4A, PDE4B, PDE4D | SLC6A4 1865/4885SLC6A2 3271/4885SLC6A3 1230/4885 |
| US-12310944-B2 | Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof | BCHE, ACHE, BACE1 | SLC6A4 93/4885SLC6A2 8/4885SLC6A3 53/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.